^




    Show legend
    Group by Gene:
    Include preclinical:

    0
    EGFR inhibitor
    erlotinib
    1
    PD1 inhibitor
    pembrolizumab
    nivolumab
    2
    mTOR inhibitor
    everolimus
    3
    EZH2 inhibitor
    tazemetostat
    4
    pan-RAF inhibitor, Multi-tyrosine kinase inhibitor
    sorafenib
    5
    HER2 inhibitor, EGFR inhibitor
    lapatinib
    6
    VEGFR inhibitor, PDGFR inhibitor, c-KIT inhibitor
    sunitinib
    7
    Bcr-abl tyrosine kinase inhibitor, Src kinase inhibitor, c-KIT inhibitor, PDGFR β antagonist, EphA2 receptor antagonist
    dasatinib
    8
    PDGFR inhibitor, Bcr-abl tyrosine kinase inhibitor, c-KIT inhibitor
    imatinib
    9
    HER2 inhibitor, HER4 inhibitor, EGFR inhibitor
    afatinib
    10
    PDGFR inhibitor
    PDGFR inhibitor
    11
    PDGFR inhibitor, HDAC inhibitor
    PDGFR inhibitor + HDAC inhibitor
    No biomarker
    EGFR expression
    SMARCB1 negative
    PIK3CA amplification
    PIK3CA M1043I
    SMARCB1 deletion
    TMB-H
    MSI-H/dMMR
    AXL underexpression
    PTEN deletion
    STK33 underexpression
    PBRM1 mutation